Platelet functional implications of glycoprotein Ibα polymorphisms in African Americans

American Journal of Hematology

Volumn 82, Issue 1, 2007, Pages 15-22

  Williams, Marlene S ^a,b   Ng'alla, Ladina S ^a   Vaidya, Dhananjay ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Atherosclerosis; Glycoproteins; Platelets; Polymorphisms; Race

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOPROTEIN IB ALPHA; HEPARIN; HUMAN PLATELET ANTIGEN 2; METHIONINE; NITRATE; STATINE; THREONINE; THROMBOCYTE ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ANALYZER; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DNA POLYMORPHISM; EUROPEAN AMERICAN; FEMALE; GENE FREQUENCY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROTEIN BINDING; RISK FACTOR; SHEAR STRESS; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOSIS;

AFRICAN AMERICANS; AGED; ALLELES; ANTIGENS, HUMAN PLATELET; ATHEROSCLEROSIS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; MIDDLE AGED; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; THROMBOSIS; UNITED STATES;

EID: 33845915113     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.20763     Document Type: Article

References (29)

1. Murata M, Matsubara Y, Kawano K, et al. Coronary artery disease and polymorphisms in a receptor mediating shear stress-dependent platelet activation. Circulation 1997;96:3281-3286.
2. Lopez JA, Berndt M. The GPIb-IX-V complex. In: Michelson A, editor. Platelets. New York: Elsevier; 2002. pp 85-104.
3. Fredrickson BJ, Dong JF, McIntire LV, Lopez JA. Shear-dependent rolling on von Willebrand factor of mammalian cells expressing the platelet glycoprotein Ib-IX-V complex. Blood 1998;92:3684-3693.
4. Harker LA, Hanson SR, Kelly AB. Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation. Thromb Haemost 1997;78:736-741.
5. Kuijpers RW, Faber NM, Cuypers HT, Ouwehand WH, von dem Borne AE. NH2-terminal globular domain of human platelet glycoprotein Ibα has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigens. J Clin Invest 1992;89:381-384.
6. Vicente V, Houghten RA, Ruggeri ZM. Identification of a site in the α chain of platelet glycoprotein Ib that participates in von Willebrand factor binding. J Biol Chem 1990;265:274-280.
7. Mazzucato M, Pradella P, de Angelis V, Steffan A, de Marco L. Frequency and functional relevance of genetic threonine145/methionine145 dimorphism in platelet glycoprotein Ibα in an Italian population. Transfusion 1996;36:891-894.
8. Gonzalez-Conejero R, Lozano ML, Rivera J, Corral J, Iniesta JA, Moraleda JM, Vicente V. Polymorphisms of platelet membrane glycoprotein Ib associated with arterial thrombotic disease. Blood 1998;92:2771-2776.
9. Bray PF. Platelet glycoprotein polymorphisms as risk factors for thrombosis. Curr Opin Hematol 2000;7:284-289.
10. Murata M, Furihata K, Ishida F, Russell SR, Ware J, Ruggeri ZM. Genetic and structural characterization of an amino acid dimorphism in glycoprotein Ibα involved in platelet transfusion refractoriness. Blood 1992;79:3086-3090.
11. Afshar-Kharghan V, Li CQ, Khoshnevis-Asl M, Lopez JA. Kozak sequence polymorphism of the glycoprotein (GP) Ibα gene is a major determinant of the plasma membrane levels of the platelet GP Ib-IX-V complex. Blood 1999;94:186-191.
12. Baker RI, Eikelboom J, Lofthouse E, et al. Platelet glycoprotein Ibalpha Kozak polymorphism is associated with an increased risk of ischemic stroke. Blood 2001;98:36-40.
13. Corral J, Lozano ML, Gonzalez-Conejero R, et al. A common polymorphism flanking the ATG initiator codon of GPIbα does not affect expression and is not a major risk factor for arterial thrombosis. Thromb Haemost 2000;83:23-28.
14. Santoso S, Zimmermann P, Sachs UJ, Gardemann A. The impact of the Kozak sequence polymorphism of the glycoprotein Ibα gene on the risk and extent of coronary heart disease. Thromb Haemost 2002;87:345-346.
15. Huang T, Sahud MA. Association of C807T, P1(A), and -5 C/T Kozak genotypes with density of glycoprotein receptors on platelet surface. Thromb Res 2003;112:147-150.
16. Williams MS, Coller BS, Vaananen HJ, Scudder LE, Sharma SK, Marmur JD. Activation of platelets in platelet-rich plasma by rotablation is speed-dependent and can be inhibited by abciximab (c7E3 Fab; ReoPro). Circulation 1998;98:742-748.
17. Minino AM, Arias E, Kochanek KD, Murphy SL, Smith BL. Deaths: Final data for 2000. Natl Vital Stat Rep 2002;50:1-119.
18. Kim HO, Jin Y, Kickler TS, Blakemore K, Kwon OH, Bray PF. Gene frequencies of the five major human platelet antigens in African American, white, and Korean populations. Transfusion 1995;35:863-867.
19. Aramaki KM, Reiner AP. A novel isoform of platelet glycoprotein Ibα is prevalent in African Americans. Am J Hematol 1999; 60:77-79.
20. Theodoropoulos I, Christopoulos C, Metcalfe P, Dimitriadou E, Economopoulos P, Loucopoulos D. The effect of human platelet alloantigen polymorphisms on the in vitro responsiveness to adrenaline and collagen. Br J Haematol 2001;114:387-393.
21. Jilma-Stohlawetz P, Homoncik M, Jilma B, et al. Glycoprotein Ib polymorphisms influence platelet plug formation under high shear rates. Br J Haematol 2003; 120:652-655.
22. Ishida F, Saji H, Maruya E, Furihata K. Human platelet-specific antigen, Siba, is associated with the molecular weight polymorphism of glycoprotein Ibα. Blood 1991;78:1722-1729.
23. Simsek S, von dem Borne AE. Molecular genetics of human platelet antigens. Infusionsther Transfusionsmed 1994;21 (Suppl 3): 29-33.
24. Best D, Senis YA, Jarvis GE, et al. GPVI levels in platelets: Relationship to platelet function at high shear. Blood 2003;102:2811-2818.
25. Lopez JA, Ludwig EH, McCarthy BJ. Polymorphism of human glycoprotein Ibα results from a variable number of tandem repeats of a 13-amino acid sequence in the mucin-like macroglycopeptide region. Structure/function implications. J Biol Chem 1992;267:10055-10061.
26. Ishida F, Furihata K, Ishida K, et al. The largest variant of platelet glycoprotein Ibα has four tandem repeats of 13 amino acids in the macroglycopeptide region and a genetic linkage with methionine145. Blood 1995;86:1357-1360.
27. Matsubara Y, Murata M, Hayashi T, et al. Platelet glycoprotein Ibα polymorphisms affect the interaction with von Willebrand factor under flow conditions. Br J Haematol 2005;128:533-539.
28. Macchi L, Christiaens L, Brabant S, et al. Resistance in vitro to low-dose aspirin is associated with platelet P1A1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T Kozak (GP Ibα) polymorphisms. J Am Coll Cardiol 2003;42:1115-1119.
29. Chakroun T, Gerotziafas G, Robert F, et al. In vitro aspirin resistance detected by PFA-100 closure time: pivotal role of plasma von Willebrand factor. Br J Haematol 2004;124:80-85.